This is a great update regarding new FDA regulations concerning the supply of critical foods including infant formula and medical foods.
On November 21, 2023, the Food and Drug Administration (FDA) published a one-page tip sheet for the makers of infant formula and other critical foods to educate the industry about a new requirement mandating that companies plan for supply chain or other disruptions that could impact the availability of infant formula.
View referenced article
Author(s)
Related Insights
October 6, 2026
Foley Viewpoints
What Buyers Now Diligence in AI and Autonomy Deals: Lessons from Apple's AI Acquisition
The acquisition of AI companies has become one of the most consequential deal categories in technology. Global investment in generative AI surged to $25.2 billion in 2023, and the global AI market is projected to reach $407 billion by 2027. With that growth has come a wave of acquisitions by major technology companies seeking to add AI capabilities to their platforms, and with those transactions has come a rapidly evolving diligence playbook.
October 5, 2026
Foley Viewpoints
Record Startup Shutdowns Reflect a Market That Is Moving Forward
This year, more venture-backed companies shut down than at any point on record, according to data published last week by Andreessen Horowitz. The largest share of those closures comes from companies founded between 2019 and 2021, a period when interest rates were near zero and capital was easy to raise.
October 2, 2026
Foley Viewpoints
Hard Things: Chris Yeh Says Physical AI Needs More R2-D2 and Less C-3PO
On September 28, 2026, together with our friends at Mavka Capital, Foley & Lardner Silicon Valley hosted the fourth installment of our “Hard Things” series for founders, funders and friends that are focused on building physical AI companies. The highlight of the evening was Mavka's Vitaly Golomb interview of Chris Yeh, co-author of “Blitzscaling,” about doing just that with companies building in the physical AI space.